From: Recent advances in human iPSC-derived models of the blood–brain barrier
Advantages | Highly scalable; easily measure TEER; relatively simple model for drug permeability studies; allows for investigation of paracrine signaling | Replicates in vivo physiological forces of flow and stretch; allows cell–cell contacts; mimics vasculature with microfluidic channels | Geometry mimics in vivo vessels; replicates physiological shear stress and cell–matrix interactions |
Challenges | Static culture conditions; lack of cell–cell contacts in co-culture | Limited scalability; expensive; requires specialized expertise for manufacturing; drug absorption by materials such as PDMS | Low throughput; difficult to measure TEER values and drug permeabilities; challenges with long-term stability |
Response to shear stress | |||
NVU cell–cell interactions | Lippmann [13]; Appelt-Menzel [24]; Canfield [26, 27]; Hollman [17]; Delsing [25, 28]; Mantle [45]; Stebbins [29] | ||
Drug permeability and drug delivery | Lippmann [12]; Mantle [73]; Appelt-Menzel [24]; Delsing [25]; Ribecco-Lutkiewicz [30]; Le Roux [74]; Li [71]; Ohshima [69] | ||
Neurological disease modeling | Qosa [46]; Lim [39]; Vatine [38]; Lee [41]; Al-Ahmad [72]; Katt [40]; Mantle [85]; Mohamed [47]; Page [48] | Shin [43] | |
Infectious disease modeling |